ALC
Alcon Inc.
Price Chart
Latest Quote
$66.81
+0.23 (+0.35%)
Current Price
| Previous Close | $66.58 |
| Open | $66.93 |
| Day High | $67.38 |
| Day Low | $66.38 |
| Volume | 1,251,311 |
Stock Information
| Quarterly Dividend / Yield | $0.36 / 0.54% |
| Shares Outstanding | 487.70M |
| Quarterly Dividend Yield | 0.54% |
| Quarterly Dividend | $0.36 |
| Total Debt | $5.26B |
| Cash Equivalents | $1.66B |
| Revenue | $10.63B |
| Net Income | $819.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $32.58B |
| P/E Ratio | 40.01 |
| EPS (TTM) | $1.67 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $36.19B |
| Sales | $10.63B |
| Income | $819.00M |
| Book/sh | $45.38 |
| Cash/sh | $3.40 |
| Employees | 25K |
Financial Ratios
| Quick Ratio | 1.22 |
| Current Ratio | 2.20 |
| Debt/Eq | 23.77 |
| EPS Growth TTM | -46.00% |
Returns & Margins
| ROA | 2.47% |
| ROE | 3.71% |
| Gross Margin | 55.78% |
| Operating Margin | 10.79% |
| Profit Margin | 7.70% |
Ownership
| Insider Ownership | 0.17% |
| Institutional Ownership | 66.74% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 16.83 |
| PEG | 1.51 |
| P/S | 3.06 |
| P/B | 1.47 |
Analyst Data
| Recommendation | buy |
| Target Price | $88.52 |
Technical Indicators
| SMA20 | $65.41 |
| SMA50 | $71.30 |
| SMA200 | $76.36 |
| RSI | 63.38 |
| ATR | 1.4686 |
| Shares Float | 486.15M |
| Short Ratio | 2.80 |
| Volatility | 0.70 |
| Rel Volume | 0.54 |
Performance History
| Week | +0.78% |
| Month | +2.14% |
| Quarter | -17.45% |
| 6 Months | -16.11% |
| YTD | -13.48% |
| Year | -21.88% |
| 3 Years | -12.66% |
| 5 Years | -2.40% |
| 10 Years | +17.34% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $66.81 | 1,356,100 |
| 2026-06-04 | $66.58 | 2,317,100 |
| 2026-06-03 | $64.22 | 2,571,900 |
| 2026-06-02 | $64.28 | 2,270,500 |
| 2026-06-01 | $65.70 | 1,926,100 |
| 2026-05-29 | $66.29 | 2,878,100 |
| 2026-05-28 | $65.66 | 2,396,600 |
| 2026-05-27 | $66.35 | 2,518,300 |
| 2026-05-26 | $67.70 | 2,288,800 |
| 2026-05-22 | $67.78 | 2,003,000 |
| 2026-05-21 | $67.93 | 2,358,100 |
| 2026-05-20 | $67.28 | 3,014,700 |
| 2026-05-19 | $66.28 | 3,522,600 |
| 2026-05-18 | $65.97 | 2,673,800 |
| 2026-05-15 | $63.64 | 2,131,700 |
| 2026-05-14 | $64.00 | 1,515,100 |
| 2026-05-13 | $63.44 | 1,496,800 |
| 2026-05-12 | $63.78 | 2,842,200 |
| 2026-05-11 | $62.02 | 3,167,500 |
| 2026-05-08 | $62.56 | 4,537,500 |
| 2026-05-07 | $63.88 | 4,383,300 |
| 2026-05-06 | $65.41 | 6,909,300 |
| 2026-05-05 | $nan | 0 |
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
đ° Latest News
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
Zacks âĸ 2026-06-04T15:56:00Z
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Zacks âĸ 2026-05-28T14:02:00Z
Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap
Simply Wall St. âĸ 2026-05-26T04:30:28Z
Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide?
Simply Wall St. âĸ 2026-05-25T13:15:32Z
Reasons to Retain STE Stock in Your Portfolio for Now
Zacks âĸ 2026-05-22T16:15:00Z
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1
Investing.com âĸ 2026-05-20T19:33:24ZEYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands
Zacks âĸ 2026-05-15T18:17:00Z
Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction
Insider Monkey âĸ 2026-05-15T11:50:18Z
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
Zacks âĸ 2026-05-14T17:08:00Z
How The Alcidion Group (ASX:ALC) Story Is Evolving As Guidance And Valuation Converge
Simply Wall St. âĸ 2026-05-13T03:17:46Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,656,000,000 | $4,399,000,000 | $4,208,000,000 | $3,969,000,000 |
| Cost Of Revenue | $4,656,000,000 | $4,399,000,000 | $4,208,000,000 | $3,969,000,000 |
| Total Revenue | $10,401,000,000 | $9,911,000,000 | $9,455,000,000 | $8,717,000,000 |
| Operating Revenue | $10,319,000,000 | $9,836,000,000 | $9,370,000,000 | $8,654,000,000 |
| Expenses | ||||
| Interest Expense | $204,000,000 | $192,000,000 | $189,000,000 | $134,000,000 |
| Total Expenses | $9,041,000,000 | $8,498,000,000 | $8,416,000,000 | $8,045,000,000 |
| Other Income Expense | $-58,000,000 | $-37,000,000 | $-52,000,000 | $-79,000,000 |
| Net Non Operating Interest Income Expense | $-142,000,000 | $-120,000,000 | $-155,000,000 | $-130,000,000 |
| Total Other Finance Cost | $12,000,000 | $12,000,000 | $11,000,000 | $12,000,000 |
| Interest Expense Non Operating | $204,000,000 | $192,000,000 | $189,000,000 | $134,000,000 |
| Operating Expense | $4,385,000,000 | $4,099,000,000 | $4,208,000,000 | $4,076,000,000 |
| Other Operating Expenses | $-54,000,000 | $-27,000,000 | $171,000,000 | $306,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Net Interest Income | $-142,000,000 | $-120,000,000 | $-155,000,000 | $-130,000,000 |
| Interest Income | $74,000,000 | $84,000,000 | $45,000,000 | $16,000,000 |
| Normalized Income | $1,013,800,000 | $1,041,504,777 | $1,021,580,000 | $392,196,000 |
| Net Income From Continuing And Discontinued Operation | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Total Operating Income As Reported | $1,360,000,000 | $1,413,000,000 | $1,039,000,000 | $672,000,000 |
| Net Income Common Stockholders | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Net Income | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Net Income Including Noncontrolling Interests | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Net Income Continuous Operations | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Pretax Income | $1,160,000,000 | $1,256,000,000 | $832,000,000 | $463,000,000 |
| Special Income Charges | $-2,000,000 | $1,000,000 | $-13,000,000 | $-21,000,000 |
| Earnings From Equity Interest | $-18,000,000 | $-8,000,000 | $0 | $0 |
| Interest Income Non Operating | $74,000,000 | $84,000,000 | $45,000,000 | $16,000,000 |
| Operating Income | $1,360,000,000 | $1,413,000,000 | $1,039,000,000 | $672,000,000 |
| Gross Profit | $5,745,000,000 | $5,512,000,000 | $5,247,000,000 | $4,748,000,000 |
| Per Share | ||||
| Diluted EPS | $1.98 | $2.05 | $1.96 | $0.68 |
| Basic EPS | $1.99 | $2.06 | $1.98 | $0.68 |
| Other | ||||
| Tax Effect Of Unusual Items | $-6,200,000 | $-5,495,223 | $-4,420,000 | $-21,804,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,739,000,000 | $2,705,000,000 | $2,294,000,000 | $1,799,000,000 |
| Total Unusual Items | $-40,000,000 | $-29,000,000 | $-52,000,000 | $-79,000,000 |
| Total Unusual Items Excluding Goodwill | $-40,000,000 | $-29,000,000 | $-52,000,000 | $-79,000,000 |
| Reconciled Depreciation | $1,335,000,000 | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 |
| EBITDA (Bullshit earnings) | $2,699,000,000 | $2,676,000,000 | $2,242,000,000 | $1,720,000,000 |
| EBIT | $1,364,000,000 | $1,448,000,000 | $1,021,000,000 | $597,000,000 |
| Diluted Average Shares | $496,200,000 | $497,500,000 | $496,500,000 | $494,400,000 |
| Basic Average Shares | $493,200,000 | $494,400,000 | $493,000,000 | $491,400,000 |
| Diluted NI Availto Com Stockholders | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Minority Interests | $0 | $0 | $0 | - |
| Tax Provision | $180,000,000 | $238,000,000 | $-142,000,000 | $128,000,000 |
| Other Special Charges | $2,000,000 | $-1,000,000 | $13,000,000 | $21,000,000 |
| Gain On Sale Of Security | $-38,000,000 | $-30,000,000 | $-39,000,000 | $-58,000,000 |
| Research And Development | $990,000,000 | $876,000,000 | $828,000,000 | $702,000,000 |
| Selling General And Administration | $3,449,000,000 | $3,250,000,000 | $3,209,000,000 | $3,068,000,000 |
Fetched: 2026-05-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $22,014,000,000 | $21,533,000,000 | $2,638,000,000 | $1,062,000,000 |
| Total Assets | $31,555,000,000 | $30,347,000,000 | $29,614,000,000 | $29,165,000,000 |
| Total Non Current Assets | $25,106,000,000 | $24,038,000,000 | $23,967,000,000 | $23,972,000,000 |
| Other Non Current Assets | $24,446,000,000 | $23,437,000,000 | $119,000,000 | $96,000,000 |
| Non Current Deferred Assets | $660,000,000 | $601,000,000 | $606,000,000 | $550,000,000 |
| Non Current Deferred Taxes Assets | $458,000,000 | $421,000,000 | $443,000,000 | $411,000,000 |
| Non Current Note Receivables | $46,000,000 | $45,000,000 | $44,000,000 | $22,000,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $4,000,000 | $1,000,000 | $1,000,000 | $20,000,000 |
| Current Assets | $6,449,000,000 | $6,309,000,000 | $5,647,000,000 | $5,193,000,000 |
| Other Current Assets | $3,929,000,000 | $3,912,000,000 | - | - |
| Hedging Assets Current | $5,000,000 | $12,000,000 | $2,000,000 | $8,000,000 |
| Prepaid Assets | $124,000,000 | $117,000,000 | $112,000,000 | $107,000,000 |
| Inventory | $2,391,000,000 | $2,268,000,000 | $2,322,000,000 | $2,109,000,000 |
| Taxes Receivable | $91,000,000 | $82,000,000 | $96,000,000 | $112,000,000 |
| Allowance For Doubtful Accounts Receivable | $-50,000,000 | $-41,000,000 | $-44,000,000 | $-57,000,000 |
| Gross Accounts Receivable | $2,129,000,000 | $1,894,000,000 | $1,930,000,000 | $1,832,000,000 |
| Cash Equivalents | $879,000,000 | $1,298,000,000 | $824,000,000 | $699,000,000 |
| Cash Financial | $648,000,000 | $378,000,000 | $270,000,000 | $281,000,000 |
| Non Current Prepaid Assets | - | $6,000,000 | $6,000,000 | $8,000,000 |
| Non Current Accounts Receivable | - | $149,000,000 | $164,000,000 | $157,000,000 |
| Investmentin Financial Assets | - | $458,000,000 | $309,000,000 | $108,000,000 |
| Goodwill And Other Intangible Assets | - | $17,533,000,000 | $17,986,000,000 | $18,615,000,000 |
| Other Intangible Assets | - | $8,587,000,000 | $9,060,000,000 | $9,689,000,000 |
| Receivables | - | $2,082,000,000 | $2,110,000,000 | $1,989,000,000 |
| Other Receivables | - | $147,000,000 | $128,000,000 | $102,000,000 |
| Accounts Receivable | - | $1,853,000,000 | $1,886,000,000 | $1,775,000,000 |
| Cash Cash Equivalents And Short Term Investments | - | $1,830,000,000 | $1,101,000,000 | $980,000,000 |
| Cash And Cash Equivalents | - | $1,676,000,000 | $1,094,000,000 | $980,000,000 |
| Debt | ||||
| Total Debt | $509,000,000 | $497,000,000 | $5,135,000,000 | $5,068,000,000 |
| Long Term Debt And Capital Lease Obligation | $429,000,000 | $429,000,000 | $5,011,000,000 | $4,900,000,000 |
| Net Debt | - | $2,963,000,000 | $3,635,000,000 | $3,658,000,000 |
| Long Term Debt | - | $4,538,000,000 | $4,676,000,000 | $4,541,000,000 |
| Current Debt And Capital Lease Obligation | - | $169,000,000 | $124,000,000 | $168,000,000 |
| Current Debt | - | $101,000,000 | $53,000,000 | $97,000,000 |
| Other Current Borrowings | - | $34,000,000 | $5,000,000 | $95,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $31,555,000,000 | $30,347,000,000 | $8,990,000,000 | $9,488,000,000 |
| Total Non Current Liabilities Net Minority Interest | $6,471,000,000 | $6,516,000,000 | $6,592,000,000 | $6,750,000,000 |
| Other Non Current Liabilities | $6,631,000,000 | $6,612,000,000 | $134,000,000 | $230,000,000 |
| Current Liabilities | $3,049,000,000 | $2,278,000,000 | $2,398,000,000 | $2,738,000,000 |
| Interest Payable | $34,000,000 | $32,000,000 | $32,000,000 | $31,000,000 |
| Income Tax Payable | $182,000,000 | $104,000,000 | $114,000,000 | $175,000,000 |
| Accounts Payable | $926,000,000 | $773,000,000 | $811,000,000 | $861,000,000 |
| Non Current Deferred Liabilities | - | $810,000,000 | $829,000,000 | $1,064,000,000 |
| Non Current Deferred Taxes Liabilities | - | $724,000,000 | $797,000,000 | $1,064,000,000 |
| Other Current Liabilities | - | $4,000,000 | $10,000,000 | $10,000,000 |
| Current Deferred Liabilities | - | $73,000,000 | $78,000,000 | $89,000,000 |
| Payables And Accrued Expenses | - | $1,497,000,000 | $1,601,000,000 | $1,736,000,000 |
| Payables | - | $982,000,000 | $1,065,000,000 | $1,200,000,000 |
| Other Payable | - | $46,000,000 | $69,000,000 | $66,000,000 |
| Total Tax Payable | - | $163,000,000 | $185,000,000 | $273,000,000 |
| Equity | ||||
| Common Stock Equity | $22,014,000,000 | $21,533,000,000 | $20,624,000,000 | $19,677,000,000 |
| Stockholders Equity | $22,014,000,000 | $21,533,000,000 | $20,624,000,000 | $19,677,000,000 |
| Gains Losses Not Affecting Retained Earnings | $22,014,000,000 | $21,533,000,000 | $20,604,000,000 | $19,657,000,000 |
| Total Equity Gross Minority Interest | - | $21,553,000,000 | $20,624,000,000 | $19,677,000,000 |
| Long Term Equity Investment | - | $293,000,000 | $10,000,000 | $0 |
| Other | ||||
| Treasury Shares Number | $12,300,000 | $5,083,676 | $6,400,000 | $7,900,000 |
| Ordinary Shares Number | $487,427,920 | $494,616,324 | $493,244,479 | $490,086,981 |
| Share Issued | $499,727,920 | $499,700,000 | $499,644,479 | $497,986,981 |
| Tangible Book Value | $22,014,000,000 | $21,533,000,000 | $2,638,000,000 | $1,062,000,000 |
| Working Capital | $3,400,000,000 | $4,031,000,000 | $3,249,000,000 | $2,455,000,000 |
| Capital Lease Obligations | $509,000,000 | $497,000,000 | $406,000,000 | $430,000,000 |
| Total Capitalization | $22,014,000,000 | $21,533,000,000 | $25,300,000,000 | $24,218,000,000 |
| Minority Interest | $1,000,000 | $0 | - | - |
| Non Current Pension And Other Postretirement Benefit Plans | $416,000,000 | $406,000,000 | $434,000,000 | $396,000,000 |
| Non Current Deferred Revenue | $91,000,000 | $86,000,000 | $32,000,000 | - |
| Long Term Capital Lease Obligation | $429,000,000 | $429,000,000 | $335,000,000 | $359,000,000 |
| Current Deferred Revenue | $84,000,000 | $73,000,000 | $78,000,000 | $89,000,000 |
| Current Capital Lease Obligation | $80,000,000 | $68,000,000 | $71,000,000 | $71,000,000 |
| Line Of Credit | $65,000,000 | $67,000,000 | $48,000,000 | $2,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $498,000,000 | $531,000,000 | $550,000,000 | $465,000,000 |
| Current Accrued Expenses | $537,000,000 | $515,000,000 | $536,000,000 | $536,000,000 |
| Investmentsin Associatesat Cost | $77,000,000 | $293,000,000 | $10,000,000 | $0 |
| Goodwill | $9,256,000,000 | $8,946,000,000 | $8,926,000,000 | $8,926,000,000 |
| Construction In Progress | $988,000,000 | $940,000,000 | $1,023,000,000 | $955,000,000 |
| Buildings And Improvements | $3,043,000,000 | $2,731,000,000 | $2,603,000,000 | $2,438,000,000 |
| Land And Improvements | $66,000,000 | $60,000,000 | $52,000,000 | $50,000,000 |
| Finished Goods | $1,725,000,000 | $1,631,000,000 | $1,691,000,000 | $1,475,000,000 |
| Work In Process | $190,000,000 | $199,000,000 | $197,000,000 | $201,000,000 |
| Raw Materials | $476,000,000 | $438,000,000 | $434,000,000 | $433,000,000 |
| Invested Capital | - | $26,192,000,000 | $25,353,000,000 | $24,315,000,000 |
| Capital Stock | - | $20,000,000 | $20,000,000 | $20,000,000 |
| Common Stock | - | $20,000,000 | $20,000,000 | $20,000,000 |
| Employee Benefits | - | $611,000,000 | $618,000,000 | $556,000,000 |
| Current Provisions | - | $4,000,000 | $35,000,000 | $270,000,000 |
| Investments And Advances | - | $751,000,000 | $319,000,000 | $108,000,000 |
| Available For Sale Securities | - | $457,000,000 | $308,000,000 | $88,000,000 |
| Net PPE | - | $4,838,000,000 | $4,723,000,000 | $4,416,000,000 |
| Accumulated Depreciation | - | $-3,199,000,000 | $-2,975,000,000 | $-2,750,000,000 |
| Gross PPE | - | $8,037,000,000 | $7,698,000,000 | $7,166,000,000 |
| Other Properties | - | $36,000,000 | $31,000,000 | $29,000,000 |
| Machinery Furniture Equipment | - | $4,270,000,000 | $3,989,000,000 | $3,694,000,000 |
| Properties | - | $0 | $0 | $0 |
| Other Short Term Investments | - | $154,000,000 | $7,000,000 | $0 |
Fetched: 2026-05-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,608,000,000 | $1,407,000,000 | $537,000,000 | $472,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,271,000,000 | $2,077,000,000 | $1,388,000,000 | $1,217,000,000 |
| Cash Flow From Continuing Operating Activities | $2,271,000,000 | $2,077,000,000 | $1,388,000,000 | $1,217,000,000 |
| Operating Gains Losses | $34,000,000 | $-33,000,000 | $27,000,000 | $10,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-663,000,000 | $-670,000,000 | $-851,000,000 | $-745,000,000 |
| Investing Cash Flow | $-1,344,000,000 | $-1,167,000,000 | $-1,094,000,000 | $-1,865,000,000 |
| Cash Flow From Continuing Investing Activities | $-1,344,000,000 | $-1,167,000,000 | $-1,094,000,000 | $-1,865,000,000 |
| Net Other Investing Changes | $-8,000,000 | $-8,000,000 | $-2,000,000 | $-485,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-676,000,000 | $0 | $0 | - |
| Financing Cash Flow | $-1,119,000,000 | $-322,000,000 | $-211,000,000 | $-8,000,000 |
| Cash Flow From Continuing Financing Activities | $-1,119,000,000 | $-322,000,000 | $-211,000,000 | $-8,000,000 |
| Net Other Financing Charges | $-246,000,000 | $-55,000,000 | $-73,000,000 | $-116,000,000 |
| Cash Dividends Paid | $-166,000,000 | $-130,000,000 | $-116,000,000 | $-100,000,000 |
| Common Stock Dividend Paid | $-166,000,000 | $-130,000,000 | $-116,000,000 | $-100,000,000 |
| Net Common Stock Issuance | $-676,000,000 | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-128,000,000 | $-196,000,000 | $-128,000,000 | $-2,378,000,000 |
| Issuance Of Debt | $97,000,000 | $59,000,000 | $106,000,000 | $2,586,000,000 |
| End Cash Position | $1,527,000,000 | $1,676,000,000 | $1,094,000,000 | $980,000,000 |
| Beginning Cash Position | $1,676,000,000 | $1,094,000,000 | $980,000,000 | $1,575,000,000 |
| Effect Of Exchange Rate Changes | $43,000,000 | $-6,000,000 | $31,000,000 | $61,000,000 |
| Changes In Cash | $-192,000,000 | $588,000,000 | $83,000,000 | $-656,000,000 |
| Common Stock Payments | $-676,000,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $-31,000,000 | $-137,000,000 | $-22,000,000 | $208,000,000 |
| Net Long Term Debt Issuance | $-31,000,000 | $-137,000,000 | $-22,000,000 | $208,000,000 |
| Long Term Debt Payments | $-128,000,000 | $-196,000,000 | $-128,000,000 | $-2,378,000,000 |
| Long Term Debt Issuance | $97,000,000 | $59,000,000 | $106,000,000 | $2,586,000,000 |
| Net Investment Purchase And Sale | $22,000,000 | $-269,000,000 | $-231,000,000 | $31,000,000 |
| Sale Of Investment | $158,000,000 | $9,000,000 | $2,000,000 | $81,000,000 |
| Purchase Of Investment | $-136,000,000 | $-278,000,000 | $-233,000,000 | $-50,000,000 |
| Net Business Purchase And Sale | $-700,000,000 | $-220,000,000 | $-10,000,000 | $-666,000,000 |
| Purchase Of Business | $-700,000,000 | $-220,000,000 | $-10,000,000 | $-666,000,000 |
| Net Intangibles Purchase And Sale | $-120,000,000 | $-197,000,000 | $-193,000,000 | $-109,000,000 |
| Purchase Of Intangibles | $-120,000,000 | $-197,000,000 | $-193,000,000 | $-109,000,000 |
| Net PPE Purchase And Sale | $-538,000,000 | $-473,000,000 | $-658,000,000 | $-636,000,000 |
| Sale Of PPE | $5,000,000 | $0 | $0 | $0 |
| Purchase Of PPE | $-543,000,000 | $-473,000,000 | $-658,000,000 | $-636,000,000 |
| Taxes Refund Paid | $-107,000,000 | $-326,000,000 | $-255,000,000 | $-178,000,000 |
| Interest Received Cfo | $63,000,000 | $69,000,000 | $33,000,000 | $14,000,000 |
| Interest Paid Cfo | $-190,000,000 | $-182,000,000 | $-176,000,000 | $-111,000,000 |
| Change In Working Capital | $-240,000,000 | $-189,000,000 | $-404,000,000 | $-522,000,000 |
| Change In Other Current Liabilities | $-24,000,000 | $-44,000,000 | $51,000,000 | $-30,000,000 |
| Change In Other Current Assets | $-47,000,000 | $-28,000,000 | $-23,000,000 | $-63,000,000 |
| Change In Payables And Accrued Expense | $116,000,000 | $-15,000,000 | $-51,000,000 | $-48,000,000 |
| Change In Payable | $116,000,000 | $-15,000,000 | $-51,000,000 | $-48,000,000 |
| Change In Account Payable | $116,000,000 | $-15,000,000 | $-51,000,000 | $-48,000,000 |
| Change In Inventory | $-156,000,000 | $-47,000,000 | $-271,000,000 | $-217,000,000 |
| Change In Receivables | $-129,000,000 | $-55,000,000 | $-110,000,000 | $-164,000,000 |
| Changes In Account Receivables | $-129,000,000 | $-55,000,000 | $-110,000,000 | $-164,000,000 |
| Other Non Cash Items | $-30,000,000 | $52,000,000 | $-62,000,000 | $105,000,000 |
| Stock Based Compensation | $162,000,000 | $150,000,000 | $144,000,000 | $140,000,000 |
| Provisionand Write Offof Assets | $84,000,000 | $52,000,000 | $21,000,000 | $187,000,000 |
| Amortization Of Securities | $0 | $0 | $7,000,000 | $-14,000,000 |
| Deferred Tax | $180,000,000 | $238,000,000 | $-142,000,000 | $128,000,000 |
| Deferred Income Tax | $180,000,000 | $238,000,000 | $-142,000,000 | $128,000,000 |
| Depreciation Amortization Depletion | $1,335,000,000 | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 |
| Depreciation And Amortization | $1,335,000,000 | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 |
| Amortization Cash Flow | $829,000,000 | $752,000,000 | $745,000,000 | $715,000,000 |
| Amortization Of Intangibles | $829,000,000 | $752,000,000 | $745,000,000 | $715,000,000 |
| Depreciation | $506,000,000 | $476,000,000 | $476,000,000 | $408,000,000 |
| Earnings Losses From Equity Investments | $18,000,000 | $8,000,000 | $0 | $0 |
| Gain Loss On Sale Of PPE | $16,000,000 | $-41,000,000 | $27,000,000 | $10,000,000 |
| Net Income From Continuing Operations | $980,000,000 | $1,018,000,000 | $974,000,000 | $335,000,000 |
| Net Short Term Debt Issuance | - | - | $43,000,000 | $-42,000,000 |
| Short Term Debt Payments | - | - | $-34,000,000 | $-42,000,000 |
| Short Term Debt Issuance | - | - | $77,000,000 | $0 |
Fetched: 2026-05-23